Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Drug Discov. 2002 Sep;1(9):710-26.

Pharmacotherapy of addictions.

Author information

1
Laboratory of the Biology of Addictive Diseases, Rockefeller University, 1230 York Avenue, New York, New York 10021, USA. kreek@mail.rockefeller.edu

Erratum in

  • Nat Rev Drug Discov 2002 Nov;1(11):920.

Abstract

Addiction to drugs, such as heroin, cocaine and alcohol, exacts great human and financial costs on society, but the development of pharmacotherapies for addiction has been largely neglected by the pharmaceutical industry. With advances in our understanding of the underlying biology of addictions now opening the door for the development of novel pharmacotherapies, it could be time for a reassessment of involvement in this increasingly important therapeutic area. Here, we summarize the current approved and implemented pharmacotherapeutic approaches to the treatment of addiction, and then highlight the most promising areas for future drug development from the perspective of our laboratory and our National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Research Center.

PMID:
12209151
DOI:
10.1038/nrd897
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group
    Loading ...
    Support Center